A new product which enables alcoholics to wean themselves off the habit gradually has been approved by the US Food and Drug Administration. Based on a traditional Chinese medicine and made up of yeasts and fermented vegetable matter extracts, the transdermal patch product, called WinoStop, maintains a steady release of alcohol into the blood stream over a 24-hour period.
"The exciting thing is that alcoholics can completely avoid withdrawal symptoms while maintaining what can best be described as a 'steady buzz' throughout the day," commented Paolo Rilf, medical director of Yu Wisch Pharmaceuticals, the Sino-US joint venture behind the project. WinoStop comes in different strengths so alcoholics can vary their 24-hour dose.
Using WinoStop, alcoholics attempting to quit can go about their daily activities with a smile, Dr Rilf added. Yu Wisch hopes eventually to get over-the-counter approval for the patch (see bottom right page 7).
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze